Larvol Delta - 23andMe-Announces-Phase-1-Results-from-the-FirstinHuman-Phase-12a-Study-of-23ME00610-an-Investigational-Antibody-Targeting-CD200R1

23ME-00610 - 23andMe

https://www.globenewswire.com/news-release/2023/04/14/2647346/0/en/23andMe-Announces-Phase-1-Results-from-the-First-in-Human-Phase-1-2a-Study-of-23ME-00610-an-Investigational-Antibody-Targeting-CD200R1.html

Apr 14, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next